BTIG on Medline Inc (MDLN): 'Overcomes Adversity and Expands Regional Footprint by 45%'
Tweet Send to a Friend
BTIG analyst David Larsen reiterated a Buy rating and $55.00 price target on Medline Inc (NASDAQ: MDLN).The analyst comments "MDLN ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
